23andMe Lays Off 40% of Staff, Shuts Drug Development Business
DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...
DNA-testing site 23andMe to lay off 40% of its workers
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
FierceBiotech6h
23andMe shutters cancer drug research programs, lays off 40% of staff
We remain deeply grateful to the patients, investigators and study staff for their participation in our clinical trials,” ...
STAT1d
The end of 23andMe’s drug discovery dream
23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...
23andMe layoffs: Company to cut 200 jobs ahead of holidays
Another Bay Area company has announced significant job cuts ahead of the holidays. Genetic testing firm 23andMe announced on ...
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 millionDiscontinues development of therapeutics division and ...
CTV News3h
23andMe cuts 40 per cent of its workforce, discontinues all therapy programs
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...
Honolulu Star-Advertiser1d
23andMe cuts 40% of its workforce, stops therapy programs
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO Anne Wojcicki.
Pittsburgh Post-Gazette on MSN5d
Nila Bala: The risks of sharing your DNA with online companies aren’t a future concern. They’re here now
DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...